$AOLS breakout climber $0.45 100% Buy http://
Post# of 63828
Posted On: 08/08/2014 7:43:36 AM
$AOLS breakout climber $0.45
100% Buy
called 9/21/13 $0.275
10-Q 5/15/14
Website
Shares Outstanding: 134.55M
Float: 33.38M
Yahoo - Press Releases
Tuesday, July 1, 2014
Aeolus Announces Additional Data Demonstrating Efficacy
of AEOL 10150 as a Medical Countermeasure Against Exposure
to Nerve Agents, Sulfur Mustard Gas and Nitrogen Mustard GasMarketwired( (Tue, Jul 1)
Wednesday, June 18, 2014
Aeolus Announces Publication of Data Demonstrating Efficacy
of AEOL 10150 in Animal CEES Model of Mustard Gas Skin
ExposureMarketwired( (Wed, Jun 18)
Monday, June 2, 2014
Aeolus Pharmateucticals to Present at LD Micro Invitational
ConferenceMarketwired( (Mon, Jun 2)
Thursday, May 15, 2014
Aeolus Announces Second Quarter Fiscal Year 2014
Financial Results and Achievements in Lung-ARS Development
ProgramMarketwired( (Thu, May 15)
Friday, February 14, 2014
Aeolus Announces First Quarter Fiscal Year 2014 Financial
ResultsMarketwired( (Fri, Feb 14)
Thursday, February 13, 2014
Aeolus Announces Process Improvements and Positive
18 Month Stability Results for AEOL 10150
in New FormulationMarketwired( (Thu, Feb 13)
Monday, February 10, 2014
Aeolus Announces Publication of Data Demonstrating Efficacy
of AEOL 10150 in Animal Model of Lung Radiation Exposure;
Models Developed for Pivotal Efficacy StudiesMarketwired( (Mon, Feb 10)
Thursday, January 23, 2014
Aeolus Receives Orphan Drug Designation for AEOL 10150 From U.S. FDAMarketwired( (Thu, Jan 23)
100% Buy
called 9/21/13 $0.275
10-Q 5/15/14
Website
Shares Outstanding: 134.55M
Float: 33.38M
Yahoo - Press Releases
Tuesday, July 1, 2014
Aeolus Announces Additional Data Demonstrating Efficacy
of AEOL 10150 as a Medical Countermeasure Against Exposure
to Nerve Agents, Sulfur Mustard Gas and Nitrogen Mustard GasMarketwired( (Tue, Jul 1)
Wednesday, June 18, 2014
Aeolus Announces Publication of Data Demonstrating Efficacy
of AEOL 10150 in Animal CEES Model of Mustard Gas Skin
ExposureMarketwired( (Wed, Jun 18)
Monday, June 2, 2014
Aeolus Pharmateucticals to Present at LD Micro Invitational
ConferenceMarketwired( (Mon, Jun 2)
Thursday, May 15, 2014
Aeolus Announces Second Quarter Fiscal Year 2014
Financial Results and Achievements in Lung-ARS Development
ProgramMarketwired( (Thu, May 15)
Friday, February 14, 2014
Aeolus Announces First Quarter Fiscal Year 2014 Financial
ResultsMarketwired( (Fri, Feb 14)
Thursday, February 13, 2014
Aeolus Announces Process Improvements and Positive
18 Month Stability Results for AEOL 10150
in New FormulationMarketwired( (Thu, Feb 13)
Monday, February 10, 2014
Aeolus Announces Publication of Data Demonstrating Efficacy
of AEOL 10150 in Animal Model of Lung Radiation Exposure;
Models Developed for Pivotal Efficacy StudiesMarketwired( (Mon, Feb 10)
Thursday, January 23, 2014
Aeolus Receives Orphan Drug Designation for AEOL 10150 From U.S. FDAMarketwired( (Thu, Jan 23)
(0)
(0)